ID   PcBra2
AC   CVCL_LE05
SY   Prostate cancer Brazil 2
DR   Wikidata; Q54938612
RX   PubMed=19997870;
CC   Doubling time: 35 hours (PubMed=19997870).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=19997870
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 28,32
ST   D2S1338: 19,23
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
RX   PubMed=19997870; DOI=10.1007/s11626-009-9249-7;
RA   Piantino, Camila Belfort
RA   Sousa-Canavez, Juliana Moreira
RA   Bellodi-Privato, Marta
RA   Srougi, Miguel
RA   Camara-Lopes, Luiz Heraldo
RA   Gattas, Gilka Jorge Figaro
RA   de Toledo Goncalves, Fernanda
RA   Fridman, Cintia
RA   Leite, Katia Ramos Moreira
RT   "Establishment and characterization of androgen-independent human
RT   prostate cancer cell lines, PcBra1, PcBra2, and PcBra3.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:123-130(2010).
//